Trading Ideas Acepodia, Inc.

Equities

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-06-19 EDT			5-day change	1st Jan Change
25.1 ^TWD	-3.28%		-8.56%	-26.50%

06-18	Acepodia, Inc. Announces Change of Chief Technology Officer, Effective June 21, 2024	CI
05-08	Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever Anti-CD20 Antibody Conjugated Allogenic Gamma Delta T Cell Therapy for Non-Hodgkins Lymphoma	CI

No results for this search